On medicine, with Dr. Eric Topol

About this episode

Thomas Goetz interviews Dr. Eric Topol about the evolution and challenges of pharmacogenomics in medicine.

20 years ago, pharmacogenomics was all the buzz: matching specific drugs to our personal DNA was supposed to transform medicine and human health. But here we are 20 years later, and much of that excitement has fizzled. Very few doctors are actually tailoring their treatments to individual patient DNA in the clinic. In this special episode, I talk with Dr. Eric Topol, author of the new book Super Agers, about the promise of pharmacogenomics and the new frontiers of medicine. We talk about how he has always put science first - he shares the story of Vioxx, a pain reliever that he was early to see carried massive risks. Eric put his career on the line to let the world know about the problems. Get full access to Drug Story at www.drugstory.co/subscribe

People in this episode

Host: Thomas Goetz

Guest: Dr. Eric Topol

Topics covered

• pharmacogenomics
• medicine
• health
• personalized treatment
• science
• risks of medication

Keywords

• pharmacogenomics
• medicine
• DNA
• personalized treatment
• Vioxx
• health
• Super Agers

Mentioned in this episode

Products: Vioxx

Books & works: Super Agers

More episodes of Drug Story

• Bonus Episode: Thomas talks with STAT · April 29, 2026 · 30 min
• On fluoride and tooth decay · March 31, 2026 · 50 min
• On ivermectin and parasites (and other things) · March 24, 2026 · 48 min
• On patent medicines (with Tim Harford) · March 17, 2026 · 39 min
• On Ambien and insomnia · March 3, 2026 · 48 min
• On chronic pain · February 24, 2026 · 51 min